{
  "docId": "019de071-f648-72d0-9c84-3373768bf908",
  "docSlug": "15eb2f0f83943ed61260bacd75adb779",
  "documentTitle": "ATAI | Investor Day Presentation Deck | 42 slides",
  "authorId": "atai",
  "authorName": "atai Life Sciences",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-01-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 4,
  "pageCount": 42,
  "prevPage": 3,
  "nextPage": 5,
  "slideType": "executive_summary",
  "function": "summarize",
  "density": "balanced",
  "nDataPoints": 4,
  "notes": "The slide uses a numbered list format to highlight key strategic pillars.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de071-f648-72d0-9c84-3373768bf908/4",
  "deckHref": "/decks/019de071-f648-72d0-9c84-3373768bf908",
  "deckJsonHref": "/decks/019de071-f648-72d0-9c84-3373768bf908.json",
  "deckAnchorHref": "/decks/019de071-f648-72d0-9c84-3373768bf908#slide-4",
  "components": [
    {
      "bbox": {
        "h": 0.65,
        "w": 0.85,
        "x": 0.07,
        "y": 0.25
      },
      "kind": "list",
      "text": "1. Mental health disorders have become one of largest global health burdens. Despite the unmet patient need, innovations remain limited.\n2. As a response to the technical risks associated with CNS drug development, atai focuses on compounds with prior evidence in humans.\n3. Our platform consists of 11 drug development programs and 6 enabling technologies, focusing on differentiated, potentially disease-modifying therapies.\n4. We employ a decentralized drug development process, leveraging the atai team and our enabling technologies to aim for improved safety, efficacy and probability of clinical success across our pipeline.\n5. Validation of atai’s operating model: IPO of COMPASS Pathways and Otsuka partnership with Perception.\n6. We have a team of more than 200 highly experienced FTEs / consultants across our platform, and a strong cash position of approx. $430M.",
      "attrs": null,
      "subkind": "numbered",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9df43ecd-3dae-4bc3-8f95-976f889bf89c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.45,
        "x": 0.05,
        "y": 0.1
      },
      "kind": "title",
      "text": "atai executive summary & key highlights",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2bcd87bb-43c7-4cb1-955a-925366f8a8a6",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Executive summary",
      "slug": "executive-summary",
      "agent": null,
      "layer": "slide",
      "matchId": "606d0087-bf35-4c7d-97e0-bfdcbd2a98fa",
      "evidence": "list/numbered: 1. Mental health disorders have become one of largest global health burdens. Despite the unmet patient need, innovations remain limited.",
      "confidence": 0.9
    }
  ],
  "frameworks": [
    {
      "name": "list-presentation",
      "slug": null,
      "matchId": "54fa736f-5764-4eb9-a4c9-46cd93c8ad47",
      "evidence": "Numbered list of key strategic highlights",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}